Return
Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential
Y
Y
W
L
Y
Q
Z
DOI:10.1016/j.intimp.2026.117005.png)
Abstract
En 中文
• SASP-driven senescence rewires cervical-cancer immunity and tumor growth. • Senolytic & SASP-blocker combo boosts chemo-radiotherapy, reverses resistance. • Senescence-targeted regimen plus fertility-sparing surgery preserves fecundity. • Senotherapeutic-immunotherapy synergy heightens anti-HPV T cell responses. • Framework for trials integrating immunomodulation with onco-fertility goals.
Journal
IF:
4.7
Papers:
1.6W
Citations:
4.1W
